⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LNTH News
Lantheus Holdings, Inc
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
globenewswire.com
LNTH
Form 8-K
sec.gov
LNTH
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
LNTH
Lantheus to Present at March 2026 Investor Conferences
globenewswire.com
LNTH
Bronstein, Gewirtz & Grossman, LLC Encourages Lantheus Holdings, Inc. (LNTH) Shareholders to Inquire about Securities Investigation
accessnewswire.com
LNTH
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Shareholders to Connect
accessnewswire.com
LNTH
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Shareholders to Reach Out
accessnewswire.com
LNTH
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
prnewswire.com
LNTH
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
LNTH
Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
globenewswire.com
LNTH